期刊文献+

常见肠、肝、肾疾病以及糖尿病状态下相关药物转运体的变化及其应用意义 被引量:9

Alteration of related transporters and its application significance in common intestinal disease, liver disease, renal disease and diabetes
原文传递
导出
摘要 转运体是位于细胞膜上的功能性膜蛋白。目前研究证明转运体在药物的吸收、分布以及排泄过程中发挥着重要的作用,其中以肠道、肝脏以及肾脏转运体的作用最为明显。疾病状态下转运体的表达和功能会发生改变,影响药物在体内的处置过程,使药物的药代动力学发生明显改变而对疾病的药物治疗产生影响。本文综述了常见肠道疾病、肝脏疾病、肾脏疾病以及糖尿病状态下相关转运体的变化及其对临床药物治疗的影响。 Drug transporters are functional membrane proteins located in various tissues, which play vital roles in absorption, distribution and excretion of drugs, especially those located in intestine, liver and kidney. The expression and function of transporters will alter in diseases state, which affects the therapeutic effects of drugs by altering their pharmacokinetics. In this review, we focus on the alterations in related transporters and the effect on the drug therapy in common intestinal diseases, liver diseases, kidney diseases and diabetes mellitus.
作者 王丽 刘克辛
出处 《药学学报》 CAS CSCD 北大核心 2015年第2期127-132,共6页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81473280 81273580)
关键词 转运体 肠道疾病 肝脏疾病 肾脏疾病 糖尿病 transporter intestinal disease liver disease kidney disease diabetes mellitus
  • 相关文献

参考文献4

二级参考文献92

  • 1Ziemann C, BLirkle A, Kahl GF, Hirsch-Ernst KI. Reactive oxygen species participate in mdrlb mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Carcinogenesis 1999; 20: 407- 14. 被引量:1
  • 2Liu H, Liu X, Jia L, Liu Y, Yang H, WangG, etal. Insulin therapy restores impaired function and expression of P-glycoprotein in blood- brain barrier of experimental diabetes. Biochem Pharmacol 2008; 75: 1649-58. 被引量:1
  • 3Bae SK, Yang SH, Lee S J, Kwon JW, Kim WB, Lee DC, et al. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin. Eur J Pharm Sci 2005; 25: 337- 45. 被引量:1
  • 4Kim YC, Oh EY, Kfm SH, Lee MG. Pharmacokinetics and pharma- codynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin. Biopharm Drug Dispos 2005; 26: 371-8. 被引量:1
  • 5Kim YC, Oh EY, Kim SH, Lee MG. Pharmacokintics of diclofenac in rat model of diabetes mellitus induced by atloxan or steptozotocin. Biopharm Drug Dispos 2006; 27: 85-92. 被引量:1
  • 6Brady JM, Cherrington N J, Hartley DP, Buist SC, Li N, Klaassen CD. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos 2002; 30" 838-44. 被引量:1
  • 7Marchetti S, Mazzanti R, Beijnen JH, Schellens JH. Concise review: clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 2007; 12: 927-41. 被引量:1
  • 8Dey S, Patel J, Anand BS, Jain-Vakkalagadda B, Kaliki P, Pal D, et al. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest Ophthalmol Vis Sci 2003; 44: 2909-18. 被引量:1
  • 9Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004; 25: 423-9. 被引量:1
  • 10Nishio N, Katsura T, Ashida K, Okuda M, Inui K. Modulation of P-glycoprotein expression in hyperthyroid rat tissues. Drug Metab Dispos 2005; 33: 1584-7. 被引量:1

共引文献67

同被引文献64

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部